MedTrace Logo

New Approaches to INOCA

NCT05740345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-02-23

No results posted yet for this study

Summary

Ischemia with non-obstructive coronary arteries (INOCA) is common in patients with angina. INOCA has been associated with an increased risk of death, myocardial infarction, and stroke, particularly in symptomatic subjects. Previous investigations have evidenced the key role of poor glycemic control and diabetes in coronary microvascular dysfunction. Metformin is an old oral antidiabetic drug which is currently used to achieve glycemic control.

Conditions

  • New Approaches in INOCA

Interventions

DRUG

Metformin

Metformin

Sponsors & Collaborators

  • Pasquale Mone

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-15
Primary Completion
2019-01-15
Completion
2021-01-15
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05740345 on ClinicalTrials.gov